Valeant bid for Allergan heats up, Pershing plans to replace Allergan board members

Allergan says it will "carefully review and consider" a revised proposal from Valeant of $53.8 billion bid—while Pershing Square, the hedge fund that owns 9.7 percent of Allergan is calling to replace the company’s board. » More

Contact Lenses and Lens Care
This is your go-to place for the latest information on contact lens fitting, lens care, and other conditions that affect successful contact lens wear. View articles, video, CME, and explore tools to pass on to your patients. Learn More.

J&J, B+L, Essilor, others fined by Chinese authorities for price fixing

Chinese authorities fined Johnson & Johnson, Baush + Lomb, Essilor International, Nikon, and Carl Zeiss Vision Guangzhou a combined total of 19.6 million yuan, or $3 million, for price fixing in the country’s contact lens and eyeglasses market. » More

Omidria receives FDA approval for use in cataract surgery, IOL replacement

The U.S. Food and Drug Administration has approved Omeros’ phenylephrine and ketorolac injection, Omidria, for use during cataract surgery and intraocular lens (IOL) replacement to maintain pupil size by preventing intraoperative miosis and to reduce postoperative pain. » More

AOA survey finds parents are unaware of infant vision needs

The American Optometric Association’s 2014 American Eye-Q survey finds only 19 percent of parents know that a child should have his first comprehensive eye assessment between six and 12 months of age. » More

CONNECT WITH Optometry Times

Join your colleagues in conversation, respond to hot-topic questions, and stay up to date on breaking news. Like and follow us today!

» Facebook

» Twitter